NATERA INC: FETAL FOCUS ACHIEVED 96% SENSITIVITY AND 98% SPECIFICITY IN VALIDATION FROM PROSPECTIVE BLINDED EXPAND CLINICAL TRIAL

Reuters · 5d ago

Please log in to view news